Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

BACKGROUND: Response to glucocorticoid (GC) monotherapy in the initial phase of remission induction treatment in childhood acute lymphoblastic leukemia (ALL) represents important biomarker of prognosis and outcome. We aimed to study variants in several pharmacogenes (NR3C1, GSTs and ABCB1) that coul...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Radiol Oncol
Glavni autori: Gasic, Vladimir, Zukic, Branka, Stankovic, Biljana, Janic, Dragana, Dokmanovic, Lidija, Lazic, Jelena, Krstovski, Nada, Dolzan, Vita, Jazbec, Janez, Pavlovic, Sonja, Kotur, Nikola
Format: Artigo
Jezik:Inglês
Izdano: Sciendo 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6137363/
https://ncbi.nlm.nih.gov/pubmed/30210047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2018-0034
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items